3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
189
Neoplasm Metastasis
19
Neoplasms
9
Ovarian Neoplasms
8
Breast Diseases
6
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Endometrial Neoplasms
4
Advanced Breast Cancer
4
Neoplasms by Site
3
Lung Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Neoplasm, Residual
2
Multiple Myeloma
2
Melanoma
2
Inflammation
2
Hematologic Neoplasms
2
Fallopian Tube Neoplasms
2
Estrogen Receptor-positive Breast Cancer
2
Interventions
palbociclib
2
Ketorolac
2
dapagliflozin
1
Tablets
1
Surgical Procedures, Operative
1
Sulindac
1
Specimen Handling
1
Rivaroxaban
1
Resistance Training
1
Radiotherapy, Conformal
1
Probiotics
1
Pregabalin
1
Plastic Surgery Procedures
1
Omeprazole
1
Neoadjuvant Therapy
1
Methods
1
Mastectomy
1
Massage
1
Losartan
1
Ibuprofen
1
Fish Oils
1
Exercise
1
Cognitive Behavioral Therapy
1
Bevacizumab
1
Art Therapy
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Inflammation
×
palbociclib
×
Breast
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled